DE2912438C2 - - Google Patents
Info
- Publication number
- DE2912438C2 DE2912438C2 DE19792912438 DE2912438A DE2912438C2 DE 2912438 C2 DE2912438 C2 DE 2912438C2 DE 19792912438 DE19792912438 DE 19792912438 DE 2912438 A DE2912438 A DE 2912438A DE 2912438 C2 DE2912438 C2 DE 2912438C2
- Authority
- DE
- Germany
- Prior art keywords
- acid
- treatment
- pityriasis
- diseases
- fatty acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000194 fatty acid Substances 0.000 claims description 12
- 201000010099 disease Diseases 0.000 claims description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 11
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- 206010033898 parapsoriasis Diseases 0.000 claims description 4
- 229920006395 saturated elastomer Polymers 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 3
- 208000000766 Pityriasis Lichenoides Diseases 0.000 claims description 2
- 201000004681 Psoriasis Diseases 0.000 claims description 2
- 206010035114 pityriasis rosea Diseases 0.000 claims description 2
- 206010035116 pityriasis rubra pilaris Diseases 0.000 claims description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
- HABLENUWIZGESP-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O.CCCCCCCCCC(O)=O HABLENUWIZGESP-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 208000017520 skin disease Diseases 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000709400 Ruba Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000011280 coal tar Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- WLGSIWNFEGRXDF-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O.CCCCCCCCCCCC(O)=O WLGSIWNFEGRXDF-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019441 ethanol Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 230000001530 keratinolytic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 235000021081 unsaturated fats Nutrition 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792912438 DE2912438A1 (de) | 1979-03-29 | 1979-03-29 | Topische verwendung von mittelkettigen fettsaeuren (c tief 6 - c tief 14 ) und alkoholischer loesungsmittel bei der behandlung erythrosquamoeser und papuloeser erkrankungen |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19792912438 DE2912438A1 (de) | 1979-03-29 | 1979-03-29 | Topische verwendung von mittelkettigen fettsaeuren (c tief 6 - c tief 14 ) und alkoholischer loesungsmittel bei der behandlung erythrosquamoeser und papuloeser erkrankungen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2912438A1 DE2912438A1 (de) | 1980-10-16 |
| DE2912438C2 true DE2912438C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1988-11-17 |
Family
ID=6066776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19792912438 Granted DE2912438A1 (de) | 1979-03-29 | 1979-03-29 | Topische verwendung von mittelkettigen fettsaeuren (c tief 6 - c tief 14 ) und alkoholischer loesungsmittel bei der behandlung erythrosquamoeser und papuloeser erkrankungen |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE2912438A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4022815A1 (de) * | 1990-07-18 | 1992-01-23 | Braun Melsungen Ag | Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen |
| DE4042437A1 (de) * | 1990-07-18 | 1992-06-11 | Braun Melsungen Ag | Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4406884A (en) | 1981-06-23 | 1983-09-27 | The Procter & Gamble Company | Topical antimicrobial composition |
| US4343798A (en) * | 1981-06-23 | 1982-08-10 | The Procter & Gamble Company | Topical antimicrobial anti-inflammatory compositions |
| DE3603595A1 (de) * | 1986-02-06 | 1987-08-13 | Beiersdorf Ag | Haarkosmetische mittel |
| US5057500A (en) * | 1990-02-12 | 1991-10-15 | Dermatologic Research Corporation | Treatment of pruritis with esters and amides |
| EP0702950A1 (de) * | 1994-09-26 | 1996-03-27 | Beiersdorf Aktiengesellschaft | Verwendung von Fettsäuren gegen Superinfektionen der Haut |
| US6699907B1 (en) | 1996-02-20 | 2004-03-02 | Westfaliasurge, Inc. | Fatty acid antimicrobial |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE890701C (de) * | 1953-08-13 | Inihausen &. Co. G. m. b. ,H., Wüten/Ruhr | Verfahren zur Herstellung eines Heilmittels gegen Hautkrankheiten | |
| DE2828352C3 (de) * | 1978-06-28 | 1981-08-20 | Dr. August Wolff Chem.-Pharm. Fabrik Gmbh & Co Kg, 4800 Bielefeld | Mittel zur Behandlung seborrhoischer Zustände |
-
1979
- 1979-03-29 DE DE19792912438 patent/DE2912438A1/de active Granted
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4022815A1 (de) * | 1990-07-18 | 1992-01-23 | Braun Melsungen Ag | Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer hauterkrankungen |
| DE4042437A1 (de) * | 1990-07-18 | 1992-06-11 | Braun Melsungen Ag | Topische verwendung von (omega)-3-fettsaeuren-zubereitungen fuer verbrennungen |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2912438A1 (de) | 1980-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1073445B1 (de) | Stoffgemisch zur topischen anwendung enthaltend olivenöl und honig | |
| DE60313597T2 (de) | Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis | |
| DE2911670A1 (de) | Arzneimittel zur therapeutischen behandlung von peripheren vaskularen erkrankungen | |
| CH668188A5 (en) | Corticosteroid ointment compsns. - comprise e.g. dexamethasone in poly:alkylene glycol base, and are used esp. for treating rhinitis | |
| DE3705151A1 (de) | Warzenmittel | |
| DE69027220T2 (de) | Zusammensetzung und verfahren zur behandlung von schmerzvollen entzündlichen oder allergischen erkrankungen | |
| DE2802924A1 (de) | Heilmittel zur behandlung von akne | |
| DE2947742A1 (de) | (beta) -cyclodextrin als anti-aknemittel | |
| DE2912438C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE2514335C3 (de) | Oral zu verabreichendes Arzneimittel mit Antiplasmin-Inhibitorwirkung | |
| DE4214953A1 (de) | Arzneimittel zur Erhöhung des Testosteronspiegels | |
| DE2164052A1 (de) | Kosmetische mittel mit nucleosidderivaten | |
| DE69927260T2 (de) | Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis | |
| DE3443242A1 (de) | Glycyrrhizin und einen wirkstoff enthaltendes arzneimittel | |
| DE3504355A1 (de) | Mittel zur regenerierung der haut | |
| DE4433666A1 (de) | Mittel zur Behandlung oder Pflege gereizter oder entzündeter Haut enthaltend einen Extrakt aus getrockneten oder frischen Spitzwegerichkraut (Plantago lanceolata. L.) in einer Grundlage, die die Anwendung auf der Haut als Stift, Roller oder Creme ermöglicht | |
| DE2720420A1 (de) | Wirkstoffkombination gegen sonnenerythem und diese enthaltendes arzneimittel | |
| DE19821971C2 (de) | Arzneimittel zur Behandlung von Psoriasis oder Neurodermitis | |
| DE3707532C2 (de) | Verwendung einer Kombination von Extr. Gingko biloba oder mindestens einem Gingkolid und Acetylsalicylsäure oder DL-Lysin-mono-acetylsalicylat oder Diflunisal zur Behandlung von Verbrennungen, Verbrühungen, Strahlenschäden und Erfrierungen | |
| WO1996012504A1 (de) | Topisch anzuwendende öl-in-wasser-formulierung | |
| DE19605659B4 (de) | Verwendung einer Kombination von beta Caroten und Vitamin E-Derivaten zur Behandlung epithelialer Differenzierungsstörungen | |
| DE1922192C2 (de) | Zusammensetzungen zur Behandlung von trophischen Störungen der Haut und Verfahren zu ihrer Herstellung | |
| DE68905788T2 (de) | Lokal anzuwendende arzneizubereitungen enthaltend ticlopidine. | |
| DE3840946A1 (de) | Verwendung von aluminiumkaliumsulfat und/oder von 1 oder mehreren seiner hydrate | |
| DE19915102A1 (de) | Verwendung von Limonen zur Behandlung oxidativer Zellschädigungen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8127 | New person/name/address of the applicant |
Owner name: DR. AUGUST WOLFF GMBH & CO KG, 4800 BIELEFELD, DE |
|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |